Applied Aerospace & Defense: A Much Healthier Proposition

Applied Aerospace & Defense shares have declined 35% since IPO, bringing valuations to more attractive levels. Applied Aerospace now trades at below 3x sales and 14–15x EBITDA, with improving earnings visibility and a growing $1.13 billion backlog. Second-half revenue guidance implies strong sequential growth, while adjusted EBITDA guidance suggests potential upside versus consensus. Valuation is no longer demanding; further pullbacks toward $10 could present a compelling entry point for gradual accumulation.